Imidazoline binding sites in Huntington's and Parkinson's disease putamen

European Journal of Pharmacology

Volumn 301, Issue 1-3, 1996, Pages

  Reynolds, Gavin P ^a   Boulton, Ruth M ^a   Pearson, Sally J ^a   Hudson, Alan L ^b   Nutt, David J ^b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Brain, human; Extrapyramidal disorder; Imidazoline I2 receptor

Indexed keywords

2 (2 BENZOFURANYL) 2 IMIDAZOLINE; IDAZOXAN; IMIDAZOLINE I2 RECEPTOR; IMIDAZOLINE RECEPTOR; RADIOLIGAND; UNCLASSIFIED DRUG;

ARTICLE; AUTOPSY; BINDING SITE; CONTROLLED STUDY; EXTRAPYRAMIDAL SYNDROME; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; NERVE CELL DEGENERATION; NIGRONEOSTRIATAL SYSTEM; PARKINSON DISEASE; PRIORITY JOURNAL; PUTAMEN;

EID: 0029997015     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00196-3     Document Type: Article

References (8)

1. Bernheimer, H., W. Birkmayer and O. Hornykiewicz, 1961, Verteilung des 5-Hydroxytryptamins (Serotonin) on Gehirn des Menschen und sein Verhalte, bei Patienten mit Parkinson Syndrom, Klin. Wschr. 39, 1056.
2. 3H]rauwolscine, Brain Res. 566, 13.
3. Dure, L.S., A.B. Young and J.B. Penney, 1991, Excitatory amino acid binding sites in the caudate nucleus and frontal cortex of Huntington's disease, Ann. Neurol. 30, 785.
4. Escriba, P.V., M. Sastre, H. Wang, S. Renunathan, D.J. Reis and J.A. Garcia-Sevilla, 1994, Immunodetection of putative imidazoline receptor proteins in the human and rat brain and other tissues, Neurosci. Lett. 178, 81.
5. 2 sites). Br. J. Pharmacol. 114, 412P.
6. Mann, J.J., R.D. Kaplan and E.D. Bird, 1986. Elevated postmortem monoamine oxidase B activity in the caudate nucleus in Huntington's disease compared to schizophrenics and controls, J. Neural Transm. 65, 277.
7. Reynolds, G.P., S.J. Pearson and K.W.G. Heathfield, 1990, Dementia in Huntington's disease is associated with neurochemical deficits in the caudate nucleus not the cerebral cortex, Neurosci. Lett. 113, 95.
8. 2 with monoamine oxidase-B sites, J. Neurochem. 61, 881.